Roster Changes: Please make sure to submit any changes in your team roster. We would like to be able to provide all team members with the latest information about the initiative and we can only do that with your help.
IV Weaning protocol for Newborns with Hypoglycemia - Whether you're a hospital that has a Level 1 nursery or a Level 4 NICU, if you administer IV therapy, this weaning protocol can optimize treatment in newborns less than 48 hours old. Written as a provider driven protocol, this resource aims to standardize and guide clinical decisions for both asymptomatic and symptomatic hypoglycemic newborns who require IV glucose treatment.
A multitude of webinars will be available on-demand to assist you in your work
Your team will need to schedule at least monthly meetings to review data, make plans for PDSA cycles, and plan for next steps.
Please set up times to meet with your Executive Champions to update them on your progress and to ask for their help to meet your goals. PQCNC would suggest you meet with them every other month but no less than every quarter.
Tracking tool to support Hypoglycemia protocol implementation - PQCNC was proud to partner with Catherine Bennett CNS, from Advocate Lutheran General Hospital in Illinois, to bring North Carolina teams this supportive tool to measure compliance of how well your unit hypoglycemia at-risk algorithm is being followed. Simple instructions to optimize use of the tool are as follows:
Simple instructions to optimize use of the tool are as follows:
Ensure nurses caring for at-risk hypoglycemic newborns are educated on the tool (they will own the success of this process)
Instruct them to introduce the tool to parents of the at-risk newborn, taking the time to outline why the tool is important, why they are monitoring their newborn and the importance of them calling the nurse prior to feeding so a pre-prandial glucose level can be obtained. (excellent opportunity to educate family)
Each time a feeding and/or intervention occurs, it should be documented on the tool
Once newborn is discharged, no longer being monitored or transferred for higher acuity care, the form should be collected and reviewed
Neonatal hypoglycemia, defined as a plasma glucose level of less than 30 mg/dL (1.65 mmol/L) in the first 24 hours of life and less than 45 mg/dL (2.5 mmol/L) thereafter, is the most common metabolic problem in newborns. Major long-term sequelae include neurologic damage resulting in mental retardation, recurrent seizure activity, developmental delay, and personality disorders. Some evidence suggests that severe hypoglycemia may impair cardiovascular function.
Clinical Report—Postnatal Glucose Homeostasis in Late-Preterm and Term Infants - Published in Pediatrics, this report provides a practical guide and algorithm for the screening and subsequent management of neonatal hypoglycemia. Highlighting the fact that no rigorous scientific definition has been reached, this influential article from 2011, continues to be endorsed today as the guidelines to manage neonatal hypoglycemia by the American Academy of Pediatrics.
Early skin-to-skin contact for mothers and their healthy newborn infants. - This extensive Cochrane review discusses the general consensus that “minimally, skin to skin contact should continue until the end of the first successful breastfeeding in order to show an effect and to enhance early infant self-regulation.” Cited in this article as one of the common reasons for separation is hypoglycemia. The review highlights evidence for a clinically meaningful increase in blood glucose in infants who received skin to skin contact and goes on to say that even if practiced for a “short time at birth [skin to skin contact] should have measurable breastfeeding effects one to four months’ post birth.”
New approaches to management of neonatal hypoglycemia. - This very informative article focuses on the role of buccal dextrose gel in the management of asymptomatic neonatal hypoglycemia and encourages the use of dextrose gel as part of a treatment protocol. Additionally, the authors support the abandonment of the intravenous dextrose bolus for the treatment of asymptomatic, hypoglycemic late preterm, LGA, SGA/IUGR, and IDM newborns.
Ready to get started and submit your team roster? Click here
PQCNC is proud to announce that registration is now open for the statewide Safe Reduction of Primary Cesarean Birth (RPC) initiative.
The RPC Expert Team will create a concise action plan which will guide hospital RPC teams in this work as well as measures which will guide teams and the collaborative in this work.
The RPC collaborative will be facilitated by the PQCNC core team working with your hospital teams and, as with all PQCNC initiatives, will include informative webinars and quarterly face to face learning sessions as well as weekly email updates to keep all apprised of new reports on the topic, opportunities to excel developed by teams, and critical developments in the collaborative.
The PQCNC RPC initiative offers your facility a unique, structured opportunity to address the challenges of safe reduction of primary cesarean birth. Our face to face learning sessions will offer CEU and CME credit.
This all is at NO cost to your hospital.
Want to join us on this incredible journey? - use the links above.